Director's Share Dealing

RNS Number : 6889D
Futura Medical PLC
25 March 2011
 



For immediate release

25 March 2011

 

 

Futura Medical plc

("Futura" or "the Company")

 

Director's Share Dealing

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that Derek Martin, Finance Director, has today exercised options over 100,000 new ordinary shares of 0.2p each in the Company at a price of £0.43 per share.

The new ordinary shares resulting from the exercise of options will rank pari passu with existing ordinary shares and are expected to be admitted to trading on AIM at 8.00am on 31 March 2011.

Following the transactions, Mr Martin's beneficial and non-beneficial holding in ordinary shares in the Company for the purposes of the AIM Rules for Companies will be 225,000 ordinary shares, representing 0.31% of the Company's share capital.

 

For any further information please contact:

 

Futura Medical plc

 

James Barder, Chief Executive

 

Tel: +44 (0)1483 685 670

mail to: james.barder@futuramedical.com

www.futuramedical.com

 

 

 

Nomura Code Securities Limited

 

Phil Walker / Giles Balleny

Tel:+44 (0)20 7776 1200

 

 

 

For media enquiries please contact:

 

 

 

Buchanan Communications

 

Mark Court / Jessica Fontaine

Tel: +44 (0)20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDKPDQOBKDNNB
UK 100

Latest directors dealings